DDMAC Letter Cites Pfizer Geodon Ad For Implying Superiority To Haloperidol
FDA also points to the journal ad’s lack of discussion of specific warnings for metabolic side effects and movement disorders.
FDA also points to the journal ad’s lack of discussion of specific warnings for metabolic side effects and movement disorders.